Financhill
Sell
48

NVEE Quote, Financials, Valuation and Earnings

Last price:
$22.10
Seasonality move :
7.72%
Day range:
$22.10 - $22.36
52-week range:
$14.75 - $26.14
Dividend yield:
0%
P/E ratio:
44.65x
P/S ratio:
1.44x
P/B ratio:
1.72x
Volume:
538.6K
Avg. volume:
786.4K
1-year change:
-4.62%
Market cap:
$1.5B
Revenue:
$941.3M
EPS (TTM):
$0.50

Earnings Data

Next earnings date for NVEE
Aug 07
2025
Most recent earnings per share
$0.01
Missed by $0.18
(May 1/2025)
Consensus Estimate
$0.19
(May 1/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NVEE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/07/2025 Q2 $253.7M -- -- $0.31 --
05/01/2025 Q1 $229.9M $234M $0.01 $0.19 -$0.18
02/20/2025 Q4 $242.2M $246.5M $0.09 $0.28 -$0.19
11/07/2024 Q3 $251.4M $250.9M $0.27 $0.40 -$0.13
08/07/2024 Q2 $235M $236.3M $0.13 $0.30 -$0.17
05/08/2024 Q1 $209.2M $213.3M $0.01 $0.19 -$0.18
02/22/2024 Q4 $217.7M $214.9M $0.16 $0.30 -$0.14
11/02/2023 Q3 $238M $237.5M $0.21 $0.36 -$0.15
08/09/2023 Q2 $222.2M $222.6M $0.25 $0.31 -$0.06
05/04/2023 Q1 $188.3M $184.3M $0.10 $0.21 -$0.11
02/23/2023 Q4 -- $189.8M $0.13 -- --
11/03/2022 Q3 -- $204.1M $0.26 -- --
08/04/2022 Q2 -- $202.7M $0.28 -- --
05/05/2022 Q1 -- $190.2M $0.14 -- --
02/28/2022 Q4 -- $188.6M $0.26 -- --
11/09/2021 Q3 -- $185.6M $0.21 -- --
08/10/2021 Q2 -- $179.5M $0.23 -- --
05/12/2021 Q1 -- $153.1M $0.10 -- --
03/02/2021 Q4 -- $161.2M $0.09 -- --
11/11/2020 Q3 -- $169.9M $0.15 -- --
08/05/2020 Q2 -- $162.7M $0.09 -- --
05/07/2020 Q1 -- $165.5M $0.08 -- --
02/26/2020 Q4 -- $132.6M $0.07 -- --
11/07/2019 Q3 -- $131M $0.12 -- --
08/07/2019 Q2 -- $128M $0.18 -- --
05/08/2019 Q1 -- $117.3M $0.11 -- --
03/07/2019 Q4 -- $115.3M $0.16 -- --
11/07/2018 Q3 -- $104.2M $0.16 -- --
08/02/2018 Q2 -- $104M $0.17 -- --
05/03/2018 Q1 -- $94.5M $0.10 -- --
03/08/2018 Q4 -- $94M $0.27 -- --
11/08/2017 Q3 -- $91.3M $0.14 -- --
08/03/2017 Q2 -- $83.7M $0.10 -- --
05/04/2017 Q1 -- $64.1M $0.05 -- --
03/09/2017 Q4 -- $63M $0.08 -- --
11/03/2016 Q3 -- $60.1M $0.08 -- --
08/05/2016 Q2 -- $55.9M $0.08 -- --
05/05/2016 Q1 -- $44.9M $0.06 -- --
03/10/2016 Q4 -- $42.3M $0.08 -- --
11/12/2015 Q3 -- $48.7M $0.10 -- --
08/13/2015 Q2 -- $34.5M $0.06 -- --

NV5 Global Earnings Questions

  • How Much did NV5 Global Generate in Revenue Last Quarter?

    NV5 Global reported $234M worth of top line sales in its most recent quarter.

  • Did NV5 Global Beat Earnings Last Quarter?

    NV5 Global announced earnings per share of $0.01 which represents a miss of analyst forecast a $0.19 per share.

  • Is NV5 Global Profitable?

    NV5 Global reported $123.2M that represents $1.95 per share over the last quarter.

  • What is the Analyst Consensus for NV5 Global EPS Next Year?

    NV5 Global's earnings are forecast to grow from $0.44 per share to $1.30 per share next year representing an increase of 196.02%.

  • When is NV5 Global's Earnings Date?

    NV5 Global's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock